arXiv:2608. 12083v1 Announce Type: cross Abstract: Graph Neural Networks (GNNs) achieve strong predictive performance on graph-structured data across domains such as chemistry, biology, and network analysis, yet they provide no intrinsic explanation of their predictions.
By David Bechtoldt, Sidney Bender
The paper introduces a fragment‑level graph encoding for molecular property prediction, using BRICS decomposition to represent molecules as graphs of synthetically meaningful fragments. This change of input representation allows any message‑passing GNN and post‑hoc attribution method to produce explanations at the functional‑group level, matching atom‑level accuracy on smaller graphs. Experiments across multiple architectures, tasks, and explainers show that fragment‑level encoding recovers known pharmacophores more reliably than post‑hoc aggregation of atom‑level explanations.
By Rafael Lopes Almeida (School of Pharmacy, University of Eastern Finland, Kuopio, Finland), Ina P\"ohner (School of Pharmacy, University of Eastern Finland, Kuopio, Finland)
SMILESGNN is a multimodal architecture that fuses a SMILES Transformer encoder with a GATv2 graph encoder through cross‑attention, enabling interpretable clinical toxicity predictions. The model retains an explicit graph branch, allowing GNNExplainer to identify substructures linked to toxicity. On the ClinTox dataset it achieves an AUC‑ROC of 0.987 and F1 of 0.906 with only 0.4 M parameters, while on Tox21 it attains a mean AUC‑ROC of 0.750, comparable to strong single‑modality baselines.
By Quang Minh Nguyen, Thuy Quynh Nguyen, Duc Minh Le, Ho Nhat Minh Nguyen, Thanh Long Dai Doan, Trong Nghia Nguyen
The paper presents a comparative analysis of six state‑of‑the‑art counterfactual explainers for graph neural networks, focusing on methods that can both add and remove edges to alter model predictions. It evaluates these explainers across diverse real‑world and synthetic datasets, covering binary and multi‑class graph and node classification tasks, using a range of quantitative and qualitative metrics. The study highlights the trade‑offs between explanation size, coverage, and quality, aiming to pinpoint each method’s strengths and weaknesses to inform future research.
By Maria Myrto Villia, Filippos Gouidis, Theodore Patkos, Panos Trahanias
arXiv:2606. 07698v1 Announce Type: cross Abstract: Graph neural networks (GNNs) applied to drug-drug interaction (DDI) prediction rely exclusively on molecular structure encoded as SMILES-derived graphs.
By Juergen Dietrich
arXiv:2607. 02212v1 Announce Type: cross Abstract: Aqueous solubility is a key property in early-stage drug discovery, but most predictive models merge physicochemical descriptors and molecular graph information into a single representation, obscuring whether a prediction is driven by global chemistry, molecular structure, or both.
By Sampreeti Bhattacharya, Arkaprava Roy